Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 5,090 shares at $82.94 ($422K) on 2018-02-16, disclosed to the SEC on 2018-02-20.
Open-market sale of $422k NKTR by SVP & Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.94 | 2,545 | $211K | 50.0% |
| 2 | $82.94 | 2,545 | $211K | 50.0% |
| Total | $82.94 avg | 5,090 | $422K | 100% |
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |